Moderna Inc on Thursday confirmed it plans to start a trial of 30,000 volunteers of its much-anticipated coronavirus vaccine in July as the company enters the final stage of testing. The Cambridge, Massachusetts-based biotech said the primary goal of the study would be to prevent symptomatic COVID-19, the disease caused by the novel coronavirus. The key secondary goal would be prevention of severe disease, as defined by keeping people out of the hospital.

from Yahoo Finance https://ift.tt/3dOa6Pc

from Yahoo Finance https://ift.tt/37n2Vv1

Menlo Therapeutics Inc.'s (NASDAQ:MNLO): Menlo Therapeutics Inc., a pharmaceutical company, focuses on developing and…

from Yahoo Finance https://ift.tt/30vmv6L